跳至主要内容
临床试验/CTRI/2025/03/081566
CTRI/2025/03/081566尚未招募不适用

Assessment of likelihood ratio of four symptoms of Rhododendron Chrysanthum in patients of cervical spondylosis

self Dr Vighnesh k1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年3月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
The expected outcome will be the prevalence of the four symptoms is higher in the population that suffering from cervical spondylosis and improved by RHODODENDRON

研究概览

简要总结

Cervical spondylosis is a degenerative disorder of the cervical spine that affects many people. It is caused by the deterioration of the cervical spine’s intervertebral discs and facet joints. Neck discomfort has a point prevalence ranging from 0.4 percent to 41.5 percent in the general population whereas the 1-year incidence varies between 4.8 percent to 79.5 percent and the lifetime prevalence can be as high as 86.8 percent. The majority of people with spondylosis abnormalities of the cervical spine on radiographic imaging are asymptomatic. While 25 percentage of people under the age of 40 exhibit some indication of degenerative changes. This number increases to 50 percentage in people over the age of 40 and 85 percentage in those over the age of 60. C6 to C7 is the most commonly impacted level followed by C5 to C6. Moreover neck pain is the most prevalent symptom of symptomatic cervical spondylosis. Research question is whether the prevalence of four predefined symptoms is higher in the population that is suffering from cervical spondylosis and is improved by RHODODENDRON CHRYSANTHUM than in the rest of the population or not. The primary objective is to assess the prevalence of selected symptoms of RHODODENDRON CHRYSANTHUM in population that suffering from cervical spondylosis and improved by RHODODENDRON CHRYSANTHUM when comparing with rest of the populations.Secondary objective is to evaluate the effectiveness of Homoeopathic medicines in cervical spondylosis. It is an open and prospective clinical study will be conducted among the Out patient and In patient Department of National Institute Of Homoeopathy (NIH), Kolkata.

Samples will be selected as per below mentioned eligibility criteria and each patient will be enrolled after taking detail appropriate consent. Duration of study will be for 18 months and treatment of each patient will be continued for a period of 4 months.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from cervical spondylosis verified by clinical examination and x ray Patients aged 18 to 75 both male and female Subjects of all socioeconomic status all religions Ability to read either Bengali Hindi or English Patients giving written consent to participate in the study Subjects who agree to comply with protocol Subjects who agree to undergo laboratory investigations whenever required.

排除标准

  • Patients with unstable psychiatric disorder Pregnant women and lactating women Immune compromised state Substance abuse or dependence Unwilling to participate or to comply with study requirements Too unwell to take part Declined to provide consent Advanced case of cervical spondylosis that require surgical correction Patients who has taken Homoeopathic medicine for any chronic illness within 3 months.

结局指标

主要结局

The expected outcome will be the prevalence of the four symptoms is higher in the population that suffering from cervical spondylosis and improved by RHODODENDRON

时间窗: base line and 4 months

CHRYSANTHUM than in the rest of population

时间窗: base line and 4 months

次要结局

  • Homoeopathic medicines are effective in cervical spondylosis(baseline and 4 months)

研究者

发起方
self Dr Vighnesh k
申办方类型
Other [self Dr Vighnesh k]
责任方
Principal Investigator
主要研究者

Dr Vighnesh K

National Institute of Homoeopathy

研究点 (1)

Loading locations...

相似试验